Assessing corticosteroid utilization and mortality risk in septic shock: insights from network meta-analysis
DOI:
https://doi.org/10.69863/dim.v1i1.5Keywords:
corticosteroids, septic shock, mortality, treatmentAbstract
BACKGROUND: Despite current guidelines recommending corticosteroid administration in septic shock management, there is ongoing controversy regarding their impact on mortality rates and the most effective corticosteroid type.
OBJECTIVES: To assess corticosteroid use and mortality risk in septic shock via network meta-analysis.
METHODS: A comprehensive network meta-analysis was undertaken by retrieving articles from PubMed, Embase, and Scopus databases. Pertinent data encompassing baseline characteristics of articles, definitions of sepsis, types of corticosteroids employed, and mortality rates were systematically extracted from each article. The Manthel Hanzhel method alongside a network meta-analysis approach was employed to evaluate the influence of corticosteroid administration on mortality risk among individuals diagnosed with septic shock.
RESULTS: Our analysis comprised a total of 50 articles. While indirect comparison failed to yield statistically significant results regarding the reduction in mortality risk, direct comparison indicated that corticosteroid administration was linked to a decreased risk of mortality among septic shock individuals (OR: 0.80; 95%CI: 0.68, 0.93; p Egger: 0.0550; p Heterogeneity: 0.0010; p: 0.0040). Furthermore, among all the types of corticosteroids analyzed, only the hydrocortisone and fludrocortisone combination demonstrated an association with reduced mortality risk in septic shock patients. Individuals receiving this combination therapy exhibited decreased likelihood of mortality compared to those receiving a placebo (OR: 0.78; 95%CI: 0.64, 0.96; p Egger: 0.3082; p Heterogeneity: 0.8570; p: 0.0190).
CONCLUSION: Our study emphasizes the significance of corticosteroid therapy, particularly highlighting the hydrocortisone and fludrocortisone combination, for septic shock management.
References
Vincent JL, Jones G, David S, et al. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care 2019;23(1):196.doi: 10.1186/s13054-019-2478-6. PMID: 31151462
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021;47(11):1181-1247.doi: 10.1007/s00134-021-06506-y. PMID: 34599691
Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23(7):1294-1303.doi: 10.1097/00003246-199507000-00021. PMID: 7600840
Rello J, Valenzuela-Sanchez F, Ruiz-Rodriguez M, et al. Sepsis: A review of advances in management. Adv Ther 2017;34(11):2393-2411.doi: 10.1007/s12325-017-0622-8. PMID: 29022217
Ramamoorthy S, Cidlowski JA. Corticosteroids: Mechanisms of action in health and disease. Rheum Dis Clin North Am 2016;42(1):15-31.doi: 10.1016/j.rdc.2015.08.002. PMID: 26611548
Pourmand A, Whiteside T, Yamane D, et al. The controversial role of corticosteroids in septic shock. Am J Emerg Med 2019;37(7):1353-1361.doi: 10.1016/j.ajem.2019.04.045. PMID: 31056383
Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358(2):111-124.doi: 10.1056/NEJMoa071366. PMID: 18184957
Prescott HC, Sussman JB. Smarter use of corticosteroids in treating patients with septic shock. JAMA Netw Open 2020;3(12):e2029323.doi: 10.1001/jamanetworkopen.2020.29323. PMID: 33301011
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 2021;10(1):89.doi: 10.1186/s13643-021-01626-4. PMID: 33781348
Mohsina S, Gurushankari B, Niranjan R, et al. Assessment of the quality of randomized controlled trials in surgery using Jadad score: Where do we stand? J Postgrad Med 2022;68(4):207-212.doi: 10.4103/jpgm.JPGM_104_21. PMID: 35417999
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25(9):603-605.doi: 10.1007/s10654-010-9491-z. PMID: 20652370
Aboab J, Polito A, Orlikowski D, et al. Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach. Crit Care Med 2008;36(5):1481-1486.doi: 10.1097/CCM.0b013e31816f48f2. PMID: 18434902
Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288(7):862-871.doi: 10.1001/jama.288.7.862. PMID: 12186604
Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med 2018;378(9):809-818.doi: 10.1056/NEJMoa1705716. PMID: 29490185
Arabi YM, Aljumah A, Dabbagh O, et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ 2010;182(18):1971-1977.doi: 10.1503/cmaj.090707. PMID: 21059778
Blum CA, Nigro N, Briel M, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2015;385(9977):1511-1518.doi: 10.1016/S0140-6736(14)62447-8. PMID: 25608756
Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26(4):645-650.doi: 10.1097/00003246-199804000-00010. PMID: 9559600
Bone RC, Fisher CJ, Jr., Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317(11):653-658.doi: 10.1056/NEJM198709103171101. PMID: 3306374
Bosch NA, Teja B, Law AC, et al. Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock. JAMA Intern Med 2023;183(5):451-459.doi: 10.1001/jamainternmed.2023.0258. PMID: 36972033
Briegel J, Jochum M, Gippner-Steppert C, et al. Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol 2001;12(17):S70-S74.doi. PMID: 11251036
Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27(4):723-732.doi: 10.1097/00003246-199904000-00025. PMID: 10321661
Chawla K, Kupfer Y, Goldman I, et al. Hydrocortisone reverses refractory septic shock. Critical Care Medicine 1999;27(1):33A.doi. PMID: 00003246-199901001-00022
Cicarelli DD, Vieira JE, Bensenor FE. Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial. Sao Paulo Med J 2007;125(4):237-241.doi: 10.1590/s1516-31802007000400009. PMID: 17992396
The-COIITSS-Study-Investigators. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: A randomized controlled trial. JAMA 2010;303(4):341-348.doi: 10.1001/jama.2010.2. PMID:
Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005;171(3):242-248.doi: 10.1164/rccm.200406-808OC. PMID: 15557131
CSG. The effectiveness of hydrocortisone in the management of severe infections: A double-blind study. JAMA 1963;183(6):462-465.doi: 10.1001/jama.1963.63700060029012. PMID:
Doluee MT, Salehi M, Mahmoudi-Gharaee A, et al. The effect of physiologic dose of intravenous hydrocortisone in patients with refractory septic shock: a randomized control trial. Journal of Emergency Practice and Trauma 2018;4(1):29-33.doi: 10.15171/jept.2017.25. PMID:
Gordon AC, Mason AJ, Perkins GD, et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med 2014;42(6):1325-1333.doi: 10.1097/CCM.0000000000000212. PMID: 24557425
Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The vanish randomized clinical trial. JAMA 2016;316(5):509-518.doi: 10.1001/jama.2016.10485. PMID: 27483065
Hu B, Li JG, Liang H, et al. The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2009;21(9):529-531.doi. PMID: 19751560
Huang R, Zhang Z, Xu M, et al. Effect of Sini decoction on function of hypothalamic-pituitary-adrenal axis in patients with sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2014;26(3):184-187.doi: 10.3760/cma.j.issn.2095-4352.2014.03.012. PMID: 24598293
Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003;167(4):512-520.doi: 10.1164/rccm.200205-446OC. PMID: 12426230
Klastersky J, Cappel R, Debusscher L. Effectiveness of betamethasone in management of severe infections. A double-blind study. N Engl J Med 1971;284(22):1248-1250.doi: 10.1056/NEJM197106032842206. PMID: 4929896
Labib HA, Hassan AI, Kamaly AM, et al. Evaluation of the role of hydrocortisone either alone or combined with fludrocortisone in the outcome of septic shock in adults. Ain-Shams J Anesthesiol 2022;14(60):s42077.doi. PMID:
Liu L, Li J, Huang YZ, et al. The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency. Zhonghua Nei Ke Za Zhi 2012;51(8):599-603.doi. PMID: 23158856
Lucas CE, Ledgerwood AM. The cardiopulmonary response to massive doses of steroids in patients with septic shock. Arch Surg 1984;119(5):537-541.doi: 10.1001/archsurg.1984.01390170037008. PMID: 6712466
Luce JM, Montgomery AB, Marks JD, et al. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988;138(1):62-68.doi: 10.1164/ajrccm/138.1.62. PMID: 3202402
Lv QQ, Gu XH, Chen QH, et al. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial. Am J Emerg Med 2017;35(12):1810-1814.doi: 10.1016/j.ajem.2017.06.004. PMID: 28615145
Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131(4):954-963.doi: 10.1378/chest.06-2100. PMID: 17426195
Meijvis SC, Hardeman H, Remmelts HH, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet 2011;377(9782):2023-2030.doi: 10.1016/S0140-6736(11)60607-7. PMID: 21636122
Mussack T, Briegel J, Schelling G, et al. Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock. Clin Chem Lab Med 2005;43(3):259-268.doi: 10.1515/CCLM.2005.044. PMID: 15843228
Oppert M, Schindler R, Husung C, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005;33(11):2457-2464.doi: 10.1097/01.ccm.0000186370.78639.23. PMID: 16276166
Raurich JM, Llompart-Pou JA, Ibanez J, et al. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients. J Crit Care 2007;22(4):324-329.doi: 10.1016/j.jcrc.2007.05.005. PMID: 18086404
Rezk NA, Ibrahim AM. Effects of methyl prednisolone in early ARDS. Egyptian Journal of Chest Diseases and Tuberculosis 2013;62(1):167-172.doi. PMID:
Rinaldi S, Adembri C, Grechi S, et al. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med 2006;34(9):2334-2339.doi: 10.1097/01.CCM.0000233872.04706.BB. PMID: 16850006
Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976;184(3):333-341.doi: 10.1097/00000658-197609000-00011. PMID: 786190
Sabry NA, Omar EE. Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings. Pharmacology & Pharmacy 2011;2(2):73.doi. PMID:
Slusher T, Gbadero D, Howard C, et al. Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis. The Pediatric infectious disease journal 1996;15(7):579-583.doi. PMID:
Snijders D, Daniels JM, de Graaff CS, et al. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med 2010;181(9):975-982.doi: 10.1164/rccm.200905-0808OC. PMID: 20133929
Sprung CL, Caralis PV, Marcial EH, et al. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984;311(18):1137-1143.doi: 10.1056/NEJM198411013111801. PMID: 6384785
Tandan SM, Guleria R, Gupta N. Low dose steroids and adrenocortical insufficiency in septic shock: a double-blind randomised controlled trial from India. Am J Respir Crit Care Med 2005;171(1):A43.doi. PMID:
Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and covid-19: The codex randomized clinical trial. JAMA 2020;324(13):1307-1316.doi: 10.1001/jama.2020.17021. PMID: 32876695
Tongyoo S, Permpikul C, Mongkolpun W, et al. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care 2016;20(1):329.doi: 10.1186/s13054-016-1511-2. PMID: 27741949
Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 2015;313(7):677-686.doi: 10.1001/jama.2015.88. PMID: 25688779
Valoor HT, Singhi S, Jayashree M. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting. Pediatr Crit Care Med 2009;10(1):121-125.doi: 10.1097/PCC.0b013e3181936ab3. PMID: 19057445
VASSCSG. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987;317(11):659-665.doi: 10.1056/NEJM198709103171102. PMID: 2888017
Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 2018;378(9):797-808.doi: 10.1056/NEJMoa1705835. PMID: 29347874
Wagner HN, Jr., Bennett IL, Jr., Lasagna L, et al. The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bull Johns Hopkins Hosp 1956;98(3):197-215.doi. PMID: 13304518
Yildiz O, Doganay M, Aygen B, et al. Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care 2002;6(3):251-259.doi: 10.1186/cc1498. PMID: 12133187
Yildiz O, Tanriverdi F, Simsek S, et al. The effects of moderate-dose steroid therapy in sepsis: A placebo-controlled, randomized study. J Res Med Sci 2011;16(11):1410-1421.doi. PMID: 22973341
Gibbison B, Lopez-Lopez JA, Higgins JP, et al. Corticosteroids in septic shock: a systematic review and network meta-analysis. Crit Care 2017;21(1):78.doi: 10.1186/s13054-017-1659-4. PMID: 28351429
Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 2004;329(7464):480.doi: 10.1136/bmj.38181.482222.55. PMID: 15289273
Lyu QQ, Chen QH, Zheng RQ, et al. Effect of low-dose hydrocortisone therapy in adult patients with septic shock: A meta-analysis with trial sequential analysis of randomized controlled trials. J Intensive Care Med 2020;35(10):971-983.doi: 10.1177/0885066618803062. PMID: 30270720
Wang C, Sun J, Zheng J, et al. Low-dose hydrocortisone therapy attenuates septic shock in adult patients but does not reduce 28-day mortality: a meta-analysis of randomized controlled trials. Anesth Analg 2014;118(2):346-357.doi: 10.1213/ANE.0000000000000050. PMID: 24445635
Fang F, Zhang Y, Tang J, et al. Association of corticosteroid treatment with outcomes in adult patients with sepsis: A systematic review and meta-analysis. JAMA Intern Med 2019;179(2):213-223.doi: 10.1001/jamainternmed.2018.5849. PMID: 30575845
Lian XJ, Huang DZ, Cao YS, et al. Reevaluating the role of corticosteroids in septic shock: An updated meta-analysis of randomized controlled trials. Biomed Res Int 2019;2019(1):3175047.doi: 10.1155/2019/3175047. PMID: 31281831
Ni YN, Liu YM, Wang YW, et al. Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis. Am J Emerg Med 2019;37(9):1657-1664.doi: 10.1016/j.ajem.2018.11.040. PMID: 30522935
Siddiqui WJ, Iyer P, Aftab G, et al. Hydrocortisone reduces 28-day mortality in septic patients: A systemic review and meta-analysis. Cureus 2019;11(6):e4914.doi: 10.7759/cureus.4914. PMID: 31423390
Yamamoto R, Nahara I, Toyosaki M, et al. Hydrocortisone with fludrocortisone for septic shock: a systematic review and meta-analysis. Acute Med Surg 2020;7(1):e563.doi: 10.1002/ams2.563. PMID: 32995018
Annane D, Cavaillon JM. Corticosteroids in sepsis: from bench to bedside? Shock 2003;20(3):197-207.doi: 10.1097/01.shk.0000079423.72656.2f. PMID: 12923489
Heming N, Sivanandamoorthy S, Meng P, et al. Immune effects of corticosteroids in sepsis. Front Immunol 2018;9(1):1736.doi: 10.3389/fimmu.2018.01736. PMID: 30105022
Hicks CW, Sweeney DA, Danner RL, et al. Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia. Intensive Care Med 2012;38(12):2063-2071.doi: 10.1007/s00134-012-2735-5. PMID: 23111805
Hicks CW, Sweeney DA, Danner RL, et al. Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock. Crit Care Med 2012;40(1):199-207.doi: 10.1097/CCM.0b013e31822efa14. PMID: 21926575
Moraes RB, Friedman G, Viana MV, et al. Aldosterone secretion in patients with septic shock: a prospective study. Arq Bras Endocrinol Metabol 2013;57(8):636-641.doi: 10.1590/s0004-27302013000800009. PMID: 24343633
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Wibowo Sutrisno, Volodymyr Dzhyvak
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
